Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to reduce the severity of infections such as bird flu, and cure chronic conditions ...

"It is well recognized that human papillomavirus (HPV), hepatitis B virus, and other viruses can cause cancer; however, the ...

Most students and staff in a Missouri school district tested positive for a respiratory virus at least once during the school ...

The systematic review provides crucial insights into the efficacy and safety of respiratory virus vaccines, supporting evidence-based immunization practices.

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States—sending greater numbers of babies and toddlers to the hospital, recent data show.

Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...

If you’re home sick right now, you’re likely not alone. It’s common for viral pathogens to spread around this time of year, ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

"ArkBio commences Phase II study of AK0610 for RSV prevention" was originally created and published by Clinical Trials Arena, ...

Study of 2,061 infants reveals RSV, HMPV, influenza, and viral co-infections significantly increase severe lower respiratory ...